IRIS
AVENALI, MICOL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.358
AS - Asia 1.002
EU - Europa 939
SA - Sud America 239
AF - Africa 22
OC - Oceania 4
Totale 3.564
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.322
CN - Cina 372
SG - Singapore 277
IE - Irlanda 230
BR - Brasile 197
RU - Federazione Russa 179
IT - Italia 173
HK - Hong Kong 165
DE - Germania 122
FI - Finlandia 71
VN - Vietnam 67
GB - Regno Unito 35
IN - India 30
FR - Francia 29
CA - Canada 22
BD - Bangladesh 18
AR - Argentina 17
NL - Olanda 16
ZA - Sudafrica 14
JP - Giappone 13
MX - Messico 12
CZ - Repubblica Ceca 10
PL - Polonia 10
SE - Svezia 10
ES - Italia 8
ID - Indonesia 8
AT - Austria 7
CO - Colombia 6
EC - Ecuador 6
TR - Turchia 6
UA - Ucraina 6
AL - Albania 5
BE - Belgio 5
KG - Kirghizistan 5
MO - Macao, regione amministrativa speciale della Cina 5
CH - Svizzera 4
IQ - Iraq 4
PK - Pakistan 4
UZ - Uzbekistan 4
AU - Australia 3
JO - Giordania 3
KR - Corea 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
VE - Venezuela 3
AZ - Azerbaigian 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
PE - Perù 2
RS - Serbia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
MA - Marocco 1
MD - Moldavia 1
MQ - Martinica 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 3.564
Salva come PNG Salva come JPEG
Città #
Dublin 219
Chandler 211
Dallas 168
Hong Kong 164
Singapore 128
Beijing 110
Ashburn 105
Boardman 74
Los Angeles 55
Helsinki 48
Munich 41
Shanghai 37
New York 36
Moscow 35
Milan 33
Princeton 32
Lawrence 30
Rome 30
Medford 28
Redondo Beach 27
Ho Chi Minh City 26
Nanjing 26
Wilmington 26
São Paulo 21
Turku 18
Hanoi 17
Hebei 16
The Dalles 16
Buffalo 15
Santa Clara 15
Nanchang 14
Chennai 13
Nuremberg 13
Brooklyn 12
Jacksonville 12
Falkenstein 11
Pavia 11
Tokyo 11
Amsterdam 10
Düsseldorf 10
Hangzhou 10
Orem 10
Seattle 10
Warsaw 10
Chicago 9
Fairfield 9
Johannesburg 9
Rio de Janeiro 9
Shenyang 9
Toronto 9
Changsha 8
Frankfurt am Main 8
London 8
Naples 8
Ann Arbor 7
Belo Horizonte 7
Boston 7
Brno 7
Columbus 7
Houston 7
Menlo Park 7
Norwalk 7
Stockholm 7
Florence 6
Les Paris 6
Pune 6
Tianjin 6
Bakersfield 5
Bishkek 5
Brussels 5
Elk Grove Village 5
Falls Church 5
Macao 5
Montreal 5
Tübingen 5
Washington 5
Cagliari 4
Dhaka 4
Fortaleza 4
Haiphong 4
Hyderabad 4
Messina 4
Mexico City 4
Ningbo 4
Phoenix 4
Poplar 4
Shijiazhuang 4
Tashkent 4
Tirana 4
Turin 4
Vancouver 4
Amman 3
Ankara 3
Bogotá 3
Brasília 3
Buenos Aires 3
Cape Town 3
Cremona 3
Denver 3
Guangzhou 3
Totale 2.269
Salva come PNG Salva come JPEG
Nome #
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 124
CLINICAL AND BIOCHEMICAL SIGNATURES OF GBA-RELATED PARKINSON DISEASE 117
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study 113
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism 110
Time for a consensus conference on pain in neurorehabilitation 103
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 103
Consensus on the treatment of dysphagia in Parkinson's disease 102
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 96
KCTD17-related myoclonus-dystonia syndrome: clinical and electrophysiological findings of a patient with atypical late onset 95
Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study 93
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project 92
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 92
Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: A placebo controlled study. 91
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 90
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 88
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 87
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 86
Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes 83
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 81
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 77
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 76
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 74
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 73
Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations 71
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 70
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease 64
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 63
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 57
A narrative review on the role and main findings of the Videofluoroscopic Study of Swallowing in Parkison's disease 55
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 52
Pearls & Oy-sters: Marionette Walk in Parkinson Disease 47
Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects 47
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: A 6-year longitudinal study 47
Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations 46
Bilateral Dentate Nuclei Hyperintensities and Response to 4-Aminopyridine in a Patient With Childhood-Onset GAA- FGF14 -Related Ataxia 45
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 44
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 42
Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial 42
Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) 40
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease 39
Exploring the neural and behavioral correlates of cognitive telerehabilitation in mild cognitive impairment with three distinct approaches 38
Reply to: “Increased alpha-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations” 37
From DYMUS to DYPARK: Validation of a Screening Questionnaire for Dysphagia in Parkinson’s Disease 36
Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project 35
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 35
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 34
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants 34
Parkinson disease following COVID-19: Report of six cases 34
Harmonic ratio is the most responsive trunk-acceleration derived gait index to rehabilitation in people with Parkinson’s disease at moderate disease stages 33
Proprioceptive Focal Stimulation (Equistasi®) May Improve the Quality of Gait in Middle-Moderate Parkinson's Disease Patients. Double-Blind, Double-Dummy, Randomized, Crossover, Italian Multicentric Study 33
Functional Study of SNCA p.V15A Variant: Further Linking α-Synuclein and Glucocerebrosidase 31
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale 30
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study 30
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort 30
null 30
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial 30
Pain in focal dystonias - A focused review to address an important component of the disease 26
Genetic and Epidemiological Insights into RAB32-Linked Parkinson's Disease 20
Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach 19
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 19
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study 13
Totale 3.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 5 0 12 6 4 2 1
2021/2022177 0 1 1 16 9 12 3 13 9 1 20 92
2022/2023566 56 54 5 69 33 44 1 22 256 3 15 8
2023/2024357 37 47 8 22 9 70 29 24 2 11 50 48
2024/20251.129 39 58 21 20 42 116 127 63 259 60 123 201
2025/20261.198 195 190 265 250 285 13 0 0 0 0 0 0
Totale 3.644